Synlogic, Inc. (SYBX)
NASDAQ: SYBX · Real-Time Price · USD
1.506
+0.006 (0.39%)
Aug 14, 2025, 11:17 AM - Market open
Synlogic Employees
Synlogic had 1 employees as of December 31, 2024. The number of employees decreased by 5 or -83.33% compared to the previous year.
Employees
1
Change (1Y)
-5
Growth (1Y)
-83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,043,000
Market Cap
17.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1 | -5 | -83.33% |
| Dec 31, 2023 | 6 | -66 | -91.67% |
| Dec 31, 2022 | 72 | -12 | -14.29% |
| Dec 31, 2021 | 84 | 12 | 16.67% |
| Dec 31, 2020 | 72 | -4 | -5.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SYBX News
- 9 months ago - Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Adopts Limited Duration Stockholders Rights Plan - GlobeNewsWire
- 1 year ago - Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria - GlobeNewsWire
- 1 year ago - Synlogic Provides Corporate Update and Outlook for 2024 - GlobeNewsWire